Clinical Trials in Georgia

Showing 4361-4380 of 19,050 trials

A Study of LY3549492 in Healthy Weight Adult Participants

NCT07085468

The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.

Healthy

Eli Lilly and Company1 participantsStarted Jul 2025

Scottsdale, Arizona, United States • Covina, California, United States • Northridge, California, United States +18 more locations

COMPLETEDPhase 263 miles

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

NCT04303195

The purpose of this study is to assess the safety and efficacy of various dose levels of NG101 compared with placebo in adult participants with gastroparesis during 12 weeks of treatment.

Diabetic GastroparesisIdiopathic Gastroparesis

Neurogastrx, Inc.161 participantsStarted Aug 2020

Dothan, Alabama, United States • Foley, Alabama, United States • Mobile, Alabama, United States +80 more locations

A Study of LY3549492 in Healthy Weight Adult Participants

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

Find Trials by Condition in Georgia

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

HPC Offered for PRESERVE Expansion

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

MarginProbe 2.0 Data Collection Protocol

A Pilot Randomized Controlled Trial for Hand Osteoarthritis

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)